NEVIRAPINE TABLETS FOR ORAL SUSPENSION

Clinical safety rating: safe

Induces CYP3A4 decreasing levels of many drugs Can cause severe skin reactions and hepatotoxicity.

How it works

Mechanism information is still being processed. Check the DailyMed link in the sidebar for the official prescribing information.

Tablet 200 mg - Oral

Dosage form	TABLET
Renal impairment	Consult protocols for adjustment.
Liver impairment	Consult protocols for adjustment.

Clinical note

Induces CYP3A4 decreasing levels of many drugs Can cause severe skin reactions and hepatotoxicity.

FDA category

Category Animal

hepatotoxicity

Loading safety data…

Clinical safety rating: safe

Induces CYP3A4 decreasing levels of many drugs Can cause severe skin reactions and hepatotoxicity.

Mechanism information is still being processed. Check the DailyMed link in the sidebar for the official prescribing information.

Tablet 200 mg - Oral

Dosage form	TABLET
Renal impairment	Consult protocols for adjustment.
Liver impairment	Consult protocols for adjustment.

Clinical note

Induces CYP3A4 decreasing levels of many drugs Can cause severe skin reactions and hepatotoxicity.

FDA category

Category Animal

hepatotoxicity

Loading safety data…